Who Paid My Doc
Kenneth Bevan
Dentist, General Practice Napa, CA Doctor of Dentistry
NPI 1003960030 CMS profile 317860
3434 Villa Ln Ste 100, Napa, CA 94558
General payments
$4,276
Research payments
$200
Ownership & investment interest
$0
Through program year 2025, Kenneth Bevan of Napa, CA is reported in the CMS Open Payments database as having received $4,276 across 53 general payments and $200 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 97th percentile of Dentist, General Practice profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
8 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $658 | 10 | |
| 2024 | General | $590 | 8 | |
| 2023 | General | $193 | 6 | |
| 2022 | General | $17 | 1 | |
| 2021 | General | $187 | 6 | |
| 2020 | General | $829 | 6 | |
| 2019 | General | $1,801 | 16 | |
| 2019 | Research | $200 | 2 |
Beside peers
- Kenneth Bevan
- Dentist, General Practice median
- Middle half of Dentist, General Practice
- National median
In program year 2025, general payments to Kenneth Bevan were reported at $658. Among 41,122 Dentist, General Practice profiles paid that year, the median was $75 and the middle half received between $27 and $200.
Show as a table
| Year | Kenneth Bevan | Dentist, General Practice median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $1,801 | $61 | $23–$158 | $163 |
| 2020 | $829 | $73 | $24–$142 | $114 |
| 2021 | $187 | $75 | $25–$184 | $132 |
| 2022 | $17 | $75 | $27–$198 | $149 |
| 2023 | $193 | $77 | $28–$200 | $160 |
| 2024 | $590 | $74 | $27–$187 | $164 |
| 2025 | $658 | $75 | $27–$200 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 1 drugPart D claims
16
Drug cost
$110
Branded share of claims
0%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Amoxicillin | Generic | 16 | $110 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 110,731 Part D prescribers listed as Dentist; they describe a distribution and say nothing about conduct.
Records
55 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Dentist, General Practice in California
Nathan Li
Dentist, General Practice · Lancaster, CA
Bradley Ching
Dentist, General Practice · Upland, CA
Marc Geissberger
Dentist, General Practice · Greenbrae, CA
Robert Campbell
Dentist, General Practice · Long Beach, CA
Varo Boyer
Dentist, General Practice · North Hills, CA
Michael Miyasaki
Dentist, General Practice · Sacramento, CA
Related records
Dentist, General Practice in California
Practitioners in the same specialty and state, ranked by reported value.
All Dentist, General Practice
Everyone recorded under this specialty, nationwide.
Doctors in California
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.